Elon Musk’s ambitious venture, Neuralink, achieved a significant milestone by successfully implanting its first chip in a human on a Sunday. The patient is reportedly recovering well, and initial tests indicate promising results in neuron spike detection.
Table of ContentsToggle
FDA Approval and Human Trials
Neuralink, the brain chip startup founded by Elon Musk, obtained approval from the US Food and Drug Administration (FDA) to conduct its inaugural human trial last year. Subsequently, the company actively sought volunteers willing to undergo the implantation of its revolutionary brain chips.
Telepathy – Neuralink’s First Product
Elon Musk, in a post on X (formerly Twitter), revealed details about the first Neuralink product named Telepathy. This innovative technology aims to empower individuals to control their phones or computers through mere thoughts. Initial users are expected to be those who have lost the use of their limbs, with the ultimate goal of enhancing communication for individuals like Stephen Hawking.
Bridging Minds and Devices
Musk emphasized that Telepathy would enable users to control a variety of devices through thought processes. The initial focus is on assisting individuals with paralysis, allowing them to use smartphones with their minds, eliminating the need for manual input.
Ethical Concerns and Animal Testing
While Neuralink has conducted extensive tests on animals, including videos of monkeys playing Pong using only their brains, ethical concerns have arisen. Some animal rights groups, such as the Physicians Committee for Responsible Medicine, have expressed objections to Neuralink‘s experiments with monkeys, as reported by Bloomberg.